BU researchers develop novel, woman controlled contraceptive product

(Boston University School of Medicine) Researchers from Boston University School of Medicine (BUSM) and ZabBio (San Diego, CA) have developed an anti-sperm monoclonal antibody, the Human Contraception Antibody (HCA), which they found to be safe and possess potent sperm agglutination (clumping) and immobilization activity in laboratory tests.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news